Gordon Gary B. — SEC insider filings

SEC reporting owner CIK 1811354. 12 insider filings on record with FilingPulse; latest filed 2026-11-19.

Transaction summary — filings shown

Covers all 12 filings on record, filed 2021-01-06 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Old Ayala, Inc (AYLA)Chief Medical Officer6—2 legs · 6,000 sh · $97,46912
TriSalus Life Sciences, Inc. (TLSI)Director63 legs · 29,756 sh · $86,600—6

Insider filings — Gordon Gary B.

FiledFormIssuerReported transactionsSource
2026-11-194TriSalus Life Sciences, Inc. (TLSI)Purchase (P): 10,000 @ $2.20EDGAR
2026-05-184TriSalus Life Sciences, Inc. (TLSI)Purchase (P): 10,000 @ $2.46EDGAR
2026-05-154TriSalus Life Sciences, Inc. (TLSI)Grant/award (A): 28,201 @ $0 · Grant/award (A): 24,553 @ $0 · Grant/award (A): 56,403 (derivative) @ $0EDGAR
2026-02-234TriSalus Life Sciences, Inc. (TLSI)Purchase (P): 9,756 @ $4.10EDGAR
2025-06-274TriSalus Life Sciences, Inc. (TLSI)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2025-01-314TriSalus Life Sciences, Inc. (TLSI)Grant/award (A): 35,000 (derivative) @ $0 · Grant/award (A): 6,250 (derivative) @ $0EDGAR
2023-01-234Old Ayala, Inc (AYLA)Disposition to issuer (D): 58,520 · Disposition to issuer (D): 89,000 (derivative) · Disposition to issuer (D): 19,170 (derivative) · Disposition to issuer (D): 31,950 (derivative)EDGAR
2022-05-164Ayala Pharmaceuticals, Inc. (AYLA)Grant/award (A): 50,000 @ $0EDGAR
2022-01-054Ayala Pharmaceuticals, Inc. (AYLA)Grant/award (A): 31,950 (derivative) @ $0EDGAR
2021-02-264Ayala Pharmaceuticals, Inc. (AYLA)Option exercise (M): 3,000 @ $5.16 · Sale (S): 3,000 @ $17.46 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2021-01-224Ayala Pharmaceuticals, Inc. (AYLA)Option exercise (M): 3,000 @ $5.16 · Sale (S): 3,000 @ $15.03 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2021-01-064Ayala Pharmaceuticals, Inc. (AYLA)Grant/award (A): 8,520 @ $0 · Grant/award (A): 19,170 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1811354 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs